ArticleActa pharmacologica Sinica2018

The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8.

Jia-Jie Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.